1. Evaluating orelabrutinib as a novel treatment option for relapsed/refractory chronic lymphocytic leukemia in China. (12th December 2022) Authors: Gu, Danling; Li, Jianyong; Miao, Yi Journal: Expert opinion on pharmacotherapy Issue: Volume 23:Number 18(2022) Page Start: 1979 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Exploring the significance of PAK1 through chromosome conformation signatures in ibrutinib‐resistant chronic lymphocytic leukaemia. Issue 16 (22nd July 2022) Authors: Wu, Zijuan; Wang, Luqiao; Fan, Lei; Tang, Hanning; Zuo, Xiaoling; Gu, Danling; Lu, Xueying; Li, Yue; Wu, Jiazhu; Qin, Shuchao; Xia, Yi; Zhu, Huayuan; Wang, Li; Xu, Wei; Li, Jianyong; Jin, Hui Journal: Molecular oncology Issue: Volume 16:Issue 16(2022) Page Start: 2920 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Preclinical characterization and clinical translation of pharmacodynamic markers for MK-5890: a human CD27 activating antibody for cancer immunotherapy. Issue 9 (13th September 2022) Authors: Guelen, Lars; Fischmann, Thierry O; Wong, Jerelyn; Mauze, Smita; Guadagnoli, Marco; Bąbała, Nikolina; Wagenaars, Jozef; Juan, Veronica; Rosen, David; Prosise, Winnie; Habraken, Maurice; Lodewijks, Imke; Gu, Danling; Stammen-Vogelzangs, Judith; Yu, Ying; Baker, Jeanne; Lutje Hulsik, David; Driesse... Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 9(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Single‐cell profiling‐guided combination therapy of c‐Fos and histone deacetylase inhibitors in diffuse large B‐cell lymphoma. Issue 5 (6th May 2022) Authors: Wang, Luqiao; Wu, Zijuan; Xia, Yi; Lu, Xueying; Li, Ji; Fan, Lei; Qiao, Chun; Qiu, Hairong; Gu, Danling; Xu, Wei; Li, Jianyong; Jin, Hui Journal: Clinical and translational medicine Issue: Volume 12:Issue 5(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗